Laurion Capital Management »

Dianthus Therapeutics shares owned by Laurion Capital Management

Quarter-by-quarter ownership of Dianthus Therapeutics (DNTH) shares owned by Laurion Capital Management from 13F filings

Historical chart of Laurion Capital Management investment in Dianthus Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Dianthus Therapeutics held by Laurion Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Dianthus Therapeutics by Laurion Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $766k 26k 30.00
2023-12-31 $273k 26k 10.40
2023-09-30 $498k 36k 13.67

More positions owned by Laurion Capital Management

Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)
Meta Platforms Cl A Call Option (META)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
NVIDIA Corporation Call Option (NVDA)
Apple (AAPL)
Alibaba Group Hldg Sponsored Ads Call Option (BABA)
Broadcom Call Option (AVGO)
Ishares Tr Msci Eafe Etf (EFA)
Tesla Motors Call Option (TSLA)
Boeing Company (BA)
Alphabet Cap Stk Cl A (GOOGL)
Microsoft Corporation (MSFT)
Home Depot (HD)
JPMorgan Chase & Co. Call Option (JPM)
Adobe Systems Incorporated (ADBE)

View all positions for Laurion Capital Management

Top funds holding Dianthus Therapeutics

FMR
Bain Capital Life Sciences Investors
Fairmount Funds Management
Avidity Partners Management
RA Capital Management
VR Adviser
Octagon Capital Advisors
5AM Venture Management
Dr. Jeffrey R. Jay, M.D.
Vanguard Group
Henderson Group
Point72 Asset Management
Adage Capital Partners GP
Millennium Management
Tang Capital Management

View all funds holding Dianthus Therapeutics